Do Rheumatoid Arthritis Patients Have Equal Access to Treatment With New Medicines? Tumour Necrosis Factor-Alpha Inhibitors Use in Four European Countries

Health Policy - Ireland

doi 10.1016/j.healthpol.2011.10.011